Back to SNDX
Eversept Partners, LP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$45.9M
Q3 2026
Peak value
$69.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $69.6M |
| Q1 2026 | $67.4M |
| Q2 2026 | $61.2M |
| Q3 2026 | $45.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $45.9M | 2.44M | — | — |
| Q2 2026 | $61.2M | 2.80M | — | — |
| Q1 2026 | $67.4M | 2.89M | — | — |
| Q4 2025 | $69.6M | 3.31M | — | — |
Other funds holding SNDX
$188.1M
$169.2M
$153.2M
$123.7M
$123.7M
$118.9M
$116.1M